Comments
Loading...
Bright Minds Biosciences (DRUG) Forecast
NewsEarningsBright Minds Biosciences (DRUG) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBright Minds Biosciences (NASDAQ:DRUG) Stock Quotes, Forecast and News Summary
Bright Minds Biosciences Stock (NASDAQ: DRUG) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bright Minds Biosciences (DRUG) stock?
You can purchase shares of Bright Minds Biosciences (NASDAQ:DRUG) through any online brokerage.
Who are Bright Minds Biosciences (DRUG) competitors?
There are no as such competitors for Bright Minds Biosciences.
What is the forecast, or price target, for Bright Minds Biosciences (DRUG) stock?
Bright Minds Biosciences has a consensus price target of $84.33.
What is the current price for Bright Minds Biosciences (DRUG)?
The stock price for Bright Minds Biosciences (NASDAQ: DRUG) is $36.27 last updated February 21, 2025 at 10:35 AM EST.
Does Bright Minds Biosciences (DRUG) pay a dividend?
There are no upcoming dividends for Bright Minds Biosciences.
When is Bright Minds Biosciences (NASDAQ:DRUG) reporting earnings?
Bright Minds Biosciences’s Q2 earnings are confirmed for Friday, May 16, 2025.
Is Bright Minds Biosciences (DRUG) going to split?
There is no upcoming split for Bright Minds Biosciences.
What sector and industry does Bright Minds Biosciences (DRUG) operate in?
Bright Minds Biosciences is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.